The glazing technique on these mugs, paired with the circular handle, gives off cartoon glazed donut vibes (especially the ...

Cornerstone Wealth Group LLC doubled down on Regeneron Pharmaceuticals, increasing its holdings by 114% in Q1. The fund now owns 8,270 shares worth over $5.2 million, signaling high confidence in ...

Plus more pharma news from the Pharmalot campus, brought to you by the Pharmalittle newsletter.

FREMONT, Calif., June 26, 2025 /PRNewswire/ -- Ultima Genomics, a developer of an innovative new ultra-high throughput sequencing architecture, today announced that its UG 100 ™ sequencing platform ...

Kirkland & Ellis lawyers withdrew from representing Novartis AG in a lawsuit against Regeneron Inc. a week after the firm was challenged over a potential conflict of interest.

TARRYTOWN, N.Y., June 26, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2025 financial and operating results on ...

Ultima Genomics Selected to Support the World's Largest Proteomics Studies to Date Led by Regeneron Genetics Center PR Newswire FREMONT, Calif., June 26, 2025 ...

Regeneron has launched a $200 million donation matching program to support Good Days’ Retinal Vascular and Neovascular Disease Fund. This fund helps eligible U.S. patients afford vision-saving ...

TARRYTOWN, N.Y., June 26, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2025 financial and operating results on Friday, ...

Regeneron Pharmaceuticals ((REGN)) announced an update on their ongoing clinical study. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive ...

Regeneron Pharmaceuticals is conducting a Phase 2 clinical study titled A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of siRNA Gene Silencing for the Treatment of Metabolic ...

Regeneron launches a $200 million matching donation program for Good Days’ Retinal Disease Fund to enhance patient access to medicines.